Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Type

Guidance programme

HealthTech approach

HealthTech approach

Advice programme

Area of interest

Showing 1651 to 1675 of 2570

Published guidance, NICE advice and quality standards
TitleReference numberPublishedLast updated
Impella 2.5 for haemodynamic support during high-risk percutaneous coronary interventionsMIB89
OCS Heart system for heart transplantMIB86
Spasticity in under 19s: managementCG145
Endoscopic transluminal pancreatic necrosectomyHTG421
Percutaneous insertion of craniocaudal expandable implants for vertebral compression fractureHTG422
Single-anastomosis duodeno-ileal bypass with sleeve gastrectomy for treating morbid obesityHTG423
Dapagliflozin in combination therapy for treating type 2 diabetesTA288
Nivolumab for previously treated advanced renal cell carcinomaTA417
Dapagliflozin in triple therapy for treating type 2 diabetesTA418
Apremilast for treating moderate to severe plaque psoriasisTA419
High-throughput non-invasive prenatal testing for fetal RHD genotypeHTG420
Minimal change disease and focal segmental glomerulosclerosis in adults: rituximabES1
Physical health of people in prisonNG57
Needle-free arterial non-injectable connectorMIB85
Elbasvir–grazoprevir for treating chronic hepatitis CTA413
Cobimetinib in combination with vemurafenib for treating unresectable or metastatic BRAF V600 mutation-positive melanomaTA414
Certolizumab pegol for treating rheumatoid arthritis after inadequate response to a TNF-alpha inhibitorTA415
Psychosis and schizophrenia in children and young people: recognition and managementCG155
Coeliac diseaseQS134
Children's attachmentQS133
Single-incision short sling mesh insertion for stress urinary incontinence in womenHTG419
Woundchek Protease Status for assessing elevated protease status in chronic woundsMIB83
Miniature lens system implantation for advanced age-related macular degenerationHTG418
Crizotinib for untreated anaplastic lymphoma kinase-positive advanced non-small-cell lung cancerTA406
Secukinumab for treating active ankylosing spondylitisTA407

Results per page

  1. 10
  2. 25
  3. 50
  4. All